Buprenorphine and Naloxone (Actavis Pharma, Inc.)
Welcome to the PulseAid listing for the Buprenorphine and Naloxone drug offered from Actavis Pharma, Inc.. This Partial Opioid Agonist [EPC],Partial Opioid Agonists [MoA],Opioid Antagonist [EPC],Opioid Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Actavis Pharma, Inc. |
| NON-PROPRIETARY NAME: | Buprenorphine and Naloxone |
| SUBSTANCE NAME: | BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Partial Opioid Agonist [EPC],Partial Opioid Agonists [MoA],Opioid Antagonist [EPC],Opioid Antagonists [MoA] |
| ROUTE: | SUBLINGUAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2013-03-05 |
| END MARKETING DATE: | 0000-00-00 |
Buprenorphine and Naloxone HUMAN PRESCRIPTION DRUG Details:
| Item Description | Buprenorphine and Naloxone from Actavis Pharma, Inc. |
| LABELER NAME: | Actavis Pharma, Inc. |
| DEA SCHEDULE: | CIII
|
| ACTIVE STRENGTH: | 2; .5(mg/1; mg/1) |
| START MARKETING DATE: | 2013-03-05 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0228-3154_40270c4a-8c58-4f34-a6ef-4386519007ff |
| PRODUCT NDC: | 0228-3154 |
| APPLICATION NUMBER: | ANDA091422 |
Other BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE Pharmaceutical Manufacturers / Labelers:
